Inhibitory potential of 1,10-phenanthroline against Acinetobacter baumannii
This study demonstrates that 1,10-phenanthroline exhibits potent antimicrobial and antibiofilm activity against multidrug-resistant *Acinetobacter baumannii* clinical isolates with low cytotoxicity and favorable pharmacokinetic properties, suggesting its potential as a promising therapeutic agent.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Hospitals are places where people go to heal, yet they can also be breeding grounds for a specific kind of danger: bacteria that have learned to ignore the medicines designed to kill them. Among these troublemakers is Acinetobacter baumannii, a germ that thrives in medical settings and has become increasingly difficult to treat. This bacterium is particularly clever because it relies heavily on iron to survive and grow, much like a plant needs sunlight. To build its defenses and cause infection, it must scavenge this metal from its surroundings. Scientists have long suspected that if they could block the bacterium's access to iron, they might be able to stop it in its tracks. This strategy involves using chemical compounds called chelators, which act like tiny magnets that grab onto iron and hold it tight, leaving the bacteria starving and unable to function.
A team of researchers from the Federal University of Rio Grande in Brazil decided to test this idea against ten different strains of Acinetobacter baumannii found in patients. They focused on two specific iron-grabbing compounds: ethylenediaminetetraacetic acid, commonly known as EDTA, and a substance called 1,10-phenanthroline. The goal was to see if these chemicals could stop the bacteria from growing, prevent them from forming protective shields called biofilms, and do so without harming human cells. Biofilms are slimy layers of bacteria that stick to surfaces and protect the colony from antibiotics, making infections much harder to clear. The researchers also used computer models to predict how well these chemicals might travel through the body if they were ever used as medicines.
The results showed a clear difference between the two chemicals. While both could stop the bacteria to some degree, 1,10-phenanthroline was far more effective. In the lab tests, it stopped the growth of the bacteria at very low concentrations, ranging from 0.85 to 13.5 micrograms per milliliter. In many cases, it worked better than ciprofloxacin, a standard antibiotic that the bacteria had already learned to resist. The other chemical, EDTA, required much higher amounts to achieve the same result, needing between 167.5 and 223.3 micrograms per milliliter. This suggests that 1,10-phenanthroline is a much stronger weapon against this specific germ.
The researchers then looked at how these chemicals affected the bacteria's ability to build their protective biofilm layers. They selected the strains that were best at forming these tough shields and exposed them to different amounts of the chemicals. At the highest concentration tested, which was double the amount needed to stop the bacteria from growing, 1,10-phenanthroline prevented the formation of these protective layers by nearly 89 percent in the strongest strains. This is a significant finding because biofilms are often the reason infections persist in hospitals; breaking them down could make the bacteria much more vulnerable to treatment.
Safety is just as important as effectiveness when considering a new treatment. The team tested 1,10-phenanthroline on a line of human kidney cells to see if it was toxic. Even at the highest concentration they could test, which was 1,600 micrograms per milliliter, the chemical did not kill any of the human cells. The bacteria were stopped at levels far below what would hurt human tissue, indicating that this compound could potentially be safe for use in people. In contrast, the computer models suggested that EDTA might have trouble entering the body or crossing cell membranes because it is too water-loving, whereas 1,10-phenanthroline has properties that would allow it to move more easily through the body's systems.
The study concludes that 1,10-phenanthroline is a promising candidate for fighting Acinetobacter baumannii. It stops the bacteria from growing, disrupts their protective biofilm layers, and appears safe for human cells at the levels tested. While this work was done in a laboratory setting and not yet in patients, the findings suggest that iron-chelating compounds deserve further investigation as a new way to tackle infections that current antibiotics can no longer handle. The research highlights that by targeting the bacteria's need for iron, scientists may find a new path to treating some of the most stubborn hospital infections.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.